NCT00071968View on ClinicalTrials.gov

Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

May 31, 2006

Conditions
Prostate Cancer
Interventions
DRUG

temsirolimus

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

90095-1738

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00071968 - Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse | Biotech Hunter | Biotech Hunter